Values and preferences
In low and middle-income countries where measles was historically associated with a high CFR, measles is commonly perceived as a serious disease. However, in higher-income countries, hesitant/refusing parents commonly perceived measles as low-risk, mild, treatable, or unlikely to occur. Perceptions changed during an outbreak when the risk of infection increased.Go to footnote 1
Rubella is commonly perceived as a mild illness characterized by childhood fever and rash, particularly in low- and middle-income countries.Go to footnote 2, Go to footnote 3 The misconception of the severity of risk during pregnancy can lead to vaccination coverage gaps, which have been noted among adolescent and adult males.Go to footnote 4
Mumps is commonly perceived as a mild, self-limiting childhood illness characterized by parotitis, fever, and malaise. Although most infections are self-limiting, the risk of complications increases with age, including orchitis, aseptic meningitis, encephalitis, and hearing loss. Consequently, perceived disease severity may be low despite the potential for substantial morbidity, particularly during outbreaks among adolescents and young adults.Go to footnote 5, Go to footnote 6
Please consult the relevant position papers for intervention perception for varicella.
- Go back to footnote reference 1
Wilder-Smith AB, Qureshi K. Resurgence of Measles in Europe: A Systematic Review on Parental Attitudes and Beliefs of Measles Vaccine. J Epidemiol Glob Health. 2020;10(1):46-58 doi:10.2991/jegh.k.191117.001.
- Go back to footnote reference 2
World Health Organization. Rubella vaccines: WHO position paper – July 2020. Wkly Epidemiol Rec. 2020;95(27):306–324. (https://www.who.int/publications/i/item/WHO-WER9527,accessed 1 August 2026).
- Go back to footnote reference 3
World Health Organization. Strategic Advisory Group of Experts on Immunization (SAGE) Yellow Book: October 2019. Geneva: World Health Organization; 2019. (https://www.who.int/publications/i/item/who-wer-9911-115-133, accessed 3 August 2026).
- Go back to footnote reference 4
World Health Organization. Introducing rubella vaccine into national immunization programmes: a step-by-step guide. Geneva: World Health Organization; 2015 (https://www.who.int/publications/i/item/9789241549370, accessed 21 September, 2026).
- Go back to footnote reference 5
World Health Organization. Mumps virus vaccines: WHO position paper – March 2024. Wkly Epidemiol Rec. 2024;99(11):115–133. (https://www.who.int/publications/i/item/who-wer-9911-115-133, accessed 3 August 2026).
- Go back to footnote reference 6
World Health Organization. Strategic Advisory Group of Experts on Immunization (SAGE) Yellow Book: September 2023. Geneva: World Health Organization; 2023. (https://terrance.who.int/mediacentre/data/sage/SAGE_eYB_Sept2023.pdf, accessed 7 August 2026).